Unique ID issued by UMIN | UMIN000024989 |
---|---|
Receipt number | R000028755 |
Scientific Title | Exploratory clinical study on Indocyanine Green (ICG) navigated lymph node dissection in robot-assisted radical prostatectomy |
Date of disclosure of the study information | 2017/02/01 |
Last modified on | 2018/05/28 10:44:07 |
Exploratory clinical study on Indocyanine Green (ICG) navigated lymph node dissection in robot-assisted radical prostatectomy
RARP-ICG study
Exploratory clinical study on Indocyanine Green (ICG) navigated lymph node dissection in robot-assisted radical prostatectomy
RARP-ICG study
Japan |
Prostate cancer
Urology |
Malignancy
NO
We will explore the possibility of individualized pelvic lymph node dissection according to individual differences in robot-assisted radical prostatectomy surgery.
Safety,Efficacy
Lymph flow evaluatable ratio, lymph flow pattern classifiable ratio, lymph flow pattern classifiable ratio by lesion site, classification lymph flow pattern intra-lymph node metastasis rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Diagnosis
Medicine |
After injecting ICG into the prostate gland, observe with a near infrared (NIR) camera and classify lymph flow. The ICG positive site within the template dissection area is dissected and additionally dissected out of the ICG positive site outside the template dissection supernatant is performed.
20 | years-old | <= |
75 | years-old | >= |
Male
1) Diagnosed as prostate cancer pathologically by prostate biopsy
2) Diagnosed as localized prostate cancer (T1-2N0M0) or locally advanced cancer (T3aN0M0) by DRE, CT, MRI
3) 20 years old and over, under 75
4) ECOG performance status score: 0 and 1
5) With or without measurable lesions
6) Provision of pretreatment: No history of hormone therapy, no history of surgery in the pelvis, no history of operation of the prostate
7) No restrictions on concomitant medications and combination therapy
8) With regard to complications, there is no restriction as long as it is judged that robot-assisted prostatectomy and extended lymph node dissection is possible by the attending physician
9) About patient participation The patient got consent in writing from the patient himself
Exclude those with allergic history in ICG
70
1st name | |
Middle name | |
Last name | Hiroyuki Fujimoto |
National Cancer Center Hospital:Tsukiji Campus
Urology division
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
03-3542-2511
hfujimot@ncc.go.jp
1st name | |
Middle name | |
Last name | Tomohiko Hara |
National Cancer Center Hospital:Tsukiji Campus
Urology division
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
03-3542-2511
thara@ncc.go.jp
National Cancer Center Hospital:Tsukiji Campus
Urology division
National Cancer Center Hospital:Tsukiji Campus
Government offices of other countries
NO
2017 | Year | 02 | Month | 01 | Day |
Unpublished
Open public recruiting
2016 | Year | 11 | Month | 22 | Day |
2017 | Year | 02 | Month | 01 | Day |
2020 | Year | 03 | Month | 31 | Day |
2020 | Year | 03 | Month | 31 | Day |
2020 | Year | 04 | Month | 30 | Day |
2021 | Year | 03 | Month | 31 | Day |
2016 | Year | 11 | Month | 25 | Day |
2018 | Year | 05 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028755
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |